Vitanza NA - Search Results

1

Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.

Williams JR, Young CC, Vitanza NA, McGrath M, Feroze AH, Browd SR, Hauptman JS. Williams JR, et al. Among authors: vitanza na. Neurosurg Focus. 2020 Jan 1;48(1):E4. doi: 10.3171/2019.9.FOCUS19745. Neurosurg Focus. 2020. PMID: 31896081

2

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.

Lieberman NAP, DeGolier K, Kovar HM, Davis A, Hoglund V, Stevens J, Winter C, Deutsch G, Furlan SN, Vitanza NA, Leary SES, Crane CA. Lieberman NAP, et al. Among authors: vitanza na. Neuro Oncol. 2019 Jan 1;21(1):83-94. doi: 10.1093/neuonc/noy145. Neuro Oncol. 2019. PMID: 30169876 Free PMC article.

3

Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.

Vitanza NA, Monje M. Vitanza NA, et al. Curr Treat Options Neurol. 2019 Jul 10;21(8):37. doi: 10.1007/s11940-019-0577-y. Curr Treat Options Neurol. 2019. PMID: 31290035 Free PMC article. Review.

4

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Crotty EE, Leary SES, Geyer JR, Olson JM, Millard NE, Sato AA, Ermoian RP, Cole BL, Lockwood CM, Paulson VA, Browd SR, Ellenbogen RG, Hauptman JS, Lee A, Ojemann JG, Vitanza NA. Crotty EE, et al. Among authors: vitanza na. J Neurooncol. 2020 Jul;148(3):607-617. doi: 10.1007/s11060-020-03558-w. Epub 2020 Jun 16. J Neurooncol. 2020. PMID: 32556862

5

Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma.

Vitanza NA, Khalatbari H, Ermoian R, Sarthy J, Lockwood CM, Cole BL, Leary SES. Vitanza NA, et al. J Appl Lab Med. 2021 Mar 1;6(2):550-553. doi: 10.1093/jalm/jfaa086. J Appl Lab Med. 2021. PMID: 32862234 Free article. No abstract available.

6

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Vitanza NA, Biery MC, Myers C, Ferguson E, Zheng Y, Girard EJ, Przystal JM, Park G, Noll A, Pakiam F, Winter CA, Morris SM, Sarthy J, Cole BL, Leary SES, Crane C, Lieberman NAP, Mueller S, Nazarian J, Gottardo R, Brusniak MY, Mhyre AJ, Olson JM. Vitanza NA, et al. Neuro Oncol. 2021 Mar 25;23(3):376-386. doi: 10.1093/neuonc/noaa249. Neuro Oncol. 2021. PMID: 33130903 Free PMC article.

7

Considerations when treating high-grade pediatric glioma patients with immunotherapy.

Crotty E, Downey K, Ferrerosa L, Flores C, Hegde B, Raskin S, Hwang E, Vitanza N, Okada H. Crotty E, et al. Expert Rev Neurother. 2021 Feb;21(2):205-219. doi: 10.1080/14737175.2020.1855144. Epub 2020 Dec 17. Expert Rev Neurother. 2021. PMID: 33225764 Free PMC article.

8

A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models.

Biery MC, Noll A, Myers C, Morris SM, Winter CA, Pakiam F, Cole BL, Browd SR, Olson JM, Vitanza NA. Biery MC, et al. Among authors: vitanza na. J Exp Neurol. 2020 Dec;1(4):158-167. doi: 10.33696//Neurol.1.025. J Exp Neurol. 2020. PMID: 33768215 Free PMC article.

9

MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study.

Tam LT, Yeom KW, Wright JN, Jaju A, Radmanesh A, Han M, Toescu S, Maleki M, Chen E, Campion A, Lai HA, Eghbal AA, Oztekin O, Mankad K, Hargrave D, Jacques TS, Goetti R, Lober RM, Cheshier SH, Napel S, Said M, Aquilina K, Ho CY, Monje M, Vitanza NA, Mattonen SA. Tam LT, et al. Among authors: vitanza na. Neurooncol Adv. 2021 Mar 5;3(1):vdab042. doi: 10.1093/noajnl/vdab042. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33977272 Free PMC article.

10

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.

Persson ML, Douglas AM, Alvaro F, Faridi P, Larsen MR, Alonso MM, Vitanza NA, Dun MD. Persson ML, et al. Among authors: vitanza na. Neuro Oncol. 2022 Sep 1;24(9):1408-1422. doi: 10.1093/neuonc/noac117. Neuro Oncol. 2022. PMID: 35481923 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page